
News|Articles|September 1, 2003
Cardiovascular benefit of 'polypill' evaluated in BMJ
Three different drugs at half the standard dose are estimated to reduce the risk of stroke by 63% and ischemic heart disease (IHD) events by 46% for those aged 60 to 69 years, according to a study in BMJ. Another study published in the same issue recommends that those with known occlusive vascular disease and everyone aged 55 years or older take a "polypill," including the combination of blood pressure-lowering drugs, a statin, folic acid, and aspirin.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Jascayd gets second FDA approval, this time for progressive pulmonary fibrosis
2
What NCCN’s next CMO sees ahead for cancer guidelines, access and innovation
3
5 developments in the treatment of prurgio nodularis in 2025
4
2025 FDA added indications to dermatologic medications
5




















































